Clinical Trial Update: Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pembrolizumab in combination with gemcitabine in adults with advanced mycosis fungoides or Sézary syndrome. The trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Gemzar (gemcitabine)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mycosis Fungoides, Mycosis Fungoides/Sezary Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING